Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Mass-Action Law Dynamics Theory and Algorithm for Translational and Precision Medicine Informatics
  • Language: en
  • Pages: 440

Mass-Action Law Dynamics Theory and Algorithm for Translational and Precision Medicine Informatics

  • Type: Book
  • -
  • Published: 2024-04-09
  • -
  • Publisher: Elsevier

"Mass-Action Law Dynamics Theory and Algorithm for Translational and Precision Medicine Informatics provides a comprehensive overview and update of the mass-action law-based unified dose-effect biodynamics, pharmacodynamics, bioinformatics, and the combination index theorem for synergy definition (MAL-BD/PD/BI/CI). Contents advocate the fundamental MAL-PD/BI/CI/BI principle for biomedical R&D, clinical trials protocol design computerized data analysis, illustrates the MAL-dynamics theory with sample analysis, and includes data entry and automated computer report print-outs. In 11 sections "Mass-Action Law Dynamics Theory and Algorithm for Translational and Precision Medicine Informatics lead...

Cancer Treatment Reports
  • Language: en
  • Pages: 256

Cancer Treatment Reports

  • Type: Book
  • -
  • Published: 1987
  • -
  • Publisher: Unknown

None

FDA Regulation of Ribavirin
  • Language: en
  • Pages: 288
Abstracts
  • Language: en
  • Pages: 696

Abstracts

  • Type: Book
  • -
  • Published: 2013-09-11
  • -
  • Publisher: Elsevier

Abstracts of the Sixth International Congress of Pharmacology deals with papers submitted during the pharmacology congress held at Helsinki in 1975. This collection of papers deals with research and development in pharmacology and biotherapeutic drugs. The wide array of subjects deals with the therapeutic implications of controlled drug delivery and the methods of drug application, including pharmacological investigations on cell in a culture. The book also contains papers about the interactions of neurotransmitters and the hypothalamic releasing hormones and toxins as tools in receptor studies. Some papers also deal with behavioral pharmacology that covers drug dependence, narcotic analgesi...

Journal of the National Cancer Institute
  • Language: en
  • Pages: 1010

Journal of the National Cancer Institute

  • Type: Book
  • -
  • Published: 1999
  • -
  • Publisher: Unknown

None

Mesny's Chinese Miscellany
  • Language: en
  • Pages: 548

Mesny's Chinese Miscellany

  • Type: Book
  • -
  • Published: 1896
  • -
  • Publisher: Unknown

A text book of notes on China and the Chinese.

Synergism and Antagonism in Chemotherapy
  • Language: en
  • Pages: 776

Synergism and Antagonism in Chemotherapy

  • Type: Book
  • -
  • Published: 1991
  • -
  • Publisher: Unknown

Practical, mechanism-oriented coverage of chemotherapeutic drug interactions in the clinic and in experimental model systems. Anticancer, antimicrobial, and antiviral systems are included, as well as methodology for characterization and quantization of synergism and antagonism. Annotation copyrighted by Book News, Inc., Portland, OR

NCI Monographs
  • Language: en
  • Pages: 198

NCI Monographs

  • Type: Book
  • -
  • Published: 1988
  • -
  • Publisher: Unknown

None

Official Gazette of the United States Patent and Trademark Office
  • Language: en
  • Pages: 1356

Official Gazette of the United States Patent and Trademark Office

  • Type: Book
  • -
  • Published: 2001
  • -
  • Publisher: Unknown

None

Modern Immunosuppressives
  • Language: en
  • Pages: 221

Modern Immunosuppressives

Expanding from the classic use of immunosuppressants in transplantation and rejection, this current overview highlights their new roles in clinical medicine. Immunosuppressants are at the forefront of new treatment modalities. Individual chapters focus on their use not only in prevention or treatment of transplant rejection, but also on their use in immune-complex and autoimmune diseases, including rheumatoid arthritis; on combination therapies to achieve synergy in immunosuppression; on new drugs, low molecular weight chemicals, the use of antibodies and gene therapy; on immunological tolerance to prevent or inhibit transplant rejection; and how data derived from transplant studies can be applied to other avenues of immunosuppression. Clinicians and researchers will appreciate the scope of the work and the presentation of new approaches in the rapidly developing field of immunosuppression.